skip to Main Content

Our Mission

To improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies.

Our People

Ian Chan
CHIEF EXECUTIVE OFFICER  & CO-FOUNDER

Previously US Genomics, Morgan Stanley, Bear Stearns.
Education: AB Brown University, MBA Harvard University.

Eugene Chan, M.D.
CHAIRMAN  & CO-FOUNDER

CEO, rHealth, DMI
Previously US Genomics.
Education: AB Harvard University, MD Harvard University.

Robert Markelewicz, Jr, M.D, M.M.Sc
CHIEF MEDICAL OFFICER

Previously Celgene, Acetylon, Parexel.
Education: ScB Brown University, MMSc Brown University, MD Brown University.

Axel Nielsen
CHIEF OPERATING OFFICER
Previously Takeda, Shire, Baxalta. Decode Genetics, Mckinsey.
MBA, MIT; BS, University of Iceland.
Christian Zapf
SVP CORPORATE DEVELOPMENT/GENERAL COUNSEL

Previously Nantworks, Abraxis, American Pharmaceutical Partners.
Education: J.D. Columbia; MBA Insead; BA Cambridge University

Scientific Advisory Board

Bob Langer, Ph.D.

Institute Professor at MIT with over 840 written articles and over 500 issued or pending patents. Academic Founder of Moderna, AIR; Board member of Rubius, Puretech, others.

Laurie Glimcher, M.D.

President and CEO of Dana-Farber Cancer Institute; Professor, Harvard Medical School

Rita Colwell, Ph.D.

Chairman, Canon Life Sciences; Former Director NSF, appointed by Bill Clinton.

Ronald Levy, M.D.

Professor of Medicine, Director of the Lymphoma Program, Former Chief of the Division of Oncology at Stanford University.

Shiv Pillai, M.D, Ph.D.

Professor of Medicine, Harvard Medical School

Nai-Kong Cheung, M.D, Ph.D.

Head, Neuroblastoma Program; Enid A. Haupt Chair in Pediatric Oncology

George C. Tsokos, M.D.

Professor of Medicine, Harvard Medical School. Chief, Rheumatology Division.

Infectious Disease Scientific Advisory Board

Daniel Kuritzke, M.D

Daniel Kuritzkes is the Harriet Ryan Albee Professor of Medicine at Harvard Medical School and Chief of the Division of Infectious Diseases at Brigham and Women’s Hospital in Boston, Massachusetts.  He received his B.S. and M.S. degrees from Yale University and his M.D. from Harvard Medical School.  

Steven Schnittman, M.D.

Steven is formerly VP, Bristol-Myers Squibb and formerly Chief, Medical Branch, NIAID/NIH for HIV. He received his. B.S. and M.D. degree from New York University.

George Hanna, M.D.

Formerly Therapeutic Area Head/Infectious Disease, Merck; Bristol-Myers; Massachusetts General Hospital; MD, Baylor; AB, Harvard University

Board of Directors

Ian Chan

CHIEF EXECUTIVE OFFICER & CO-FOUNDER

Eugene Chan, M.D.

CHAIRMAN & CO-FOUNDER

Bob Langer, Ph.D.
Miles Suk

Our Collaborators

Back To Top